Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

AstraZeneca doubles trial size for stroke drug

December 13, 2005 Research and Development AstraZeneca, stroke

 Late stage clinical trials of AstraZeneca’s new stroke treatment have resumed after the company decided to double the number of …
News

350 million needed for stem cell research

December 8, 2005 Research and Development

At least £350 million extra funding is needed for UK stem cell research if it is to maintain its international …
News

McKillop calls for changes to EU pharmaceutical market

December 8, 2005 Research and Development

AstraZeneca's chief executive Sir Tom McKillop says action is needed on pricing and the clinical trials environment in order to …
News

UK biotech signs $230 million deal with Genentech

December 7, 2005 Research and Development

UK biotech PIramed has signed a collaborative R&D deal with Genentech on a new class of cancer drugs, which could …
News

Pharma unprepared for shift to secondary care

November 28, 2005 Research and Development

Nine out of ten European pharmaceutical companies believe they need to make significant changes to their businesses as a result …
News

New antibody could be COPD breakthrough, say companies

November 21, 2005 Research and Development Argenta, COPD, Domantis

 Two UK biotech companies say their innovative antibody drug could be a breakthrough in treating the chronic respiratory disease COPD.Chronic …
News

Oxford and GSK to collaborate on cancer research in India

November 18, 2005 Research and Development

The University of Oxford and GlaxoSmithKline are to work together with researchers in India to set up the country's first …
News

Study results not IDEAL for Lipitor

November 16, 2005 Research and Development, Sales and Marketing

A new study of Lipitor failed to show it was better than Merck's Zocor at preventing major coronary events.Results showing …
News

Enhancing the drug development process

November 9, 2005 Research and Development

MEDICAL SOLUTIONS SPONSORED FEATURERecently, we have seen a massive increase in our knowledge and understanding of the biochemical mechanisms that, …
Feature

US acquisitions a coup for Cambridge Antibody

November 8, 2005 Research and Development

Cambridge Antibody Technology has bought two promising oncology candidates from US biotech company Genencor, and has established its first research …
News

R&D Scoreboard poor gauge of pharma investment in the UK

November 8, 2005 Research and Development AstraZeneca, GSK, Pfizer, R&D, R&D scoreboard

 The R&D Scoreboard is fundamentally flawed as a measure of R&D investment in the UK and pharmaceutical companies are continuing …
News

GSK inspires more confidence than shaky AstraZeneca

November 1, 2005 Research and Development

The UK's two pharma giants have posted strong growth in the third quarter, but investor doubts about AstraZeneca's long-term prospects …
News

Tropical disease research centre to open in Liverpool

October 31, 2005 Research and Development

A new UK research centre specialising in the development of new tropical medicines has been given the go-ahead with £18 …
News

Campaigners dismayed at unworkable partial smoking ban

October 28, 2005 Research and Development

Doctors and health campaigners have expressed their deep disappointment over the government's failure to introduce a complete smoking ban in …
News

Oxford BioMedica’s lung cancer candidate shows promise

October 25, 2005 Research and Development

A promising antibody developed by UK-based Oxford BioMedica is poised to enter clinical trials to treat lung cancer.The 5T4 antibody-targeted …
News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026